Jump Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,074
| Closed | -$294K | – | 1636 |
|
|
2024
Q4 | $294K | Sell |
14,074
-20,867
| -60% | -$435K | 0.01% | 1309 |
|
|
2024
Q3 | $695K | Buy |
+34,941
| New | +$695K | 0.01% | 972 |
|
|
2024
Q1 | – | Sell |
-64,122
| Closed | -$1.08M | – | 1945 |
|
|
2023
Q4 | $1.08M | Buy |
64,122
+32,138
| +100% | +$540K | 0.03% | 673 |
|
|
2023
Q3 | $374K | Buy |
31,984
+14,715
| +85% | +$172K | 0.01% | 1175 |
|
|
2023
Q2 | $232K | Sell |
17,269
-139,453
| -89% | -$1.87M | 0.01% | 1449 |
|
|
2023
Q1 | $2.6M | Buy |
156,722
+77,393
| +98% | +$1.28M | 0.11% | 301 |
|
|
2022
Q4 | $1.48M | Buy |
79,329
+31,829
| +67% | +$592K | 0.08% | 337 |
|
|
2022
Q3 | $609K | Sell |
47,500
-34,401
| -42% | -$441K | 0.02% | 813 |
|
|
2022
Q2 | $574K | Sell |
81,901
-21,593
| -21% | -$151K | 0.02% | 791 |
|
|
2022
Q1 | $858K | Sell |
103,494
-18,906
| -15% | -$157K | 0.04% | 583 |
|
|
2021
Q4 | $829K | Buy |
+122,400
| New | +$829K | 0.05% | 455 |
|
|
2021
Q3 | – | Sell |
-37,983
| Closed | -$219K | – | 1157 |
|
|
2021
Q2 | $219K | Sell |
37,983
-17,117
| -31% | -$98.7K | 0.02% | 817 |
|
|
2021
Q1 | $254K | Buy |
+55,100
| New | +$254K | 0.02% | 671 |
|
|
2020
Q4 | – | Sell |
-52,500
| Closed | -$156K | – | 979 |
|
|
2020
Q3 | $156K | Buy |
+52,500
| New | +$156K | 0.03% | 660 |
|